OR WAIT null SECS
November 13, 2023
Recommended medicines include treatments for generalized myasthenia gravis, glioma, neovascular age-related macular degeneration, and more.
November 09, 2023
Electronic product information for selected human medicines that have been harmonized across the European Union have been published for the first time.
The document includes recommendations for the reporting and implementation of changes to container closure system components.
November 06, 2023
Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, discusses the differences in how E&L study design should be approached based on whether the study is following ISO or USP standards.
November 03, 2023
Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, recommends some key issues that pharma manufacturers should consider when formulating products that require a medical device.
This is the second biologic approved to treat HS, a painful and reoccurring skin disease.
The EC is calling for interested parties for their safety and orphan drug committees.
According to USP, the products will advance quality and reduce risk in the development and manufacture of biologics and vaccines.
One of the main purposes of stability testing is to establish shelf life for these drug products. The goal of this paper is to create an Excel spreadsheet, which can be used for statistical testing of more than three stability batches for poolability.
November 02, 2023
A novel approach for safety assessments in inhalation drugs may avoid animal testing for drug products.